ACADIA Pharmaceuticals Inc. (ACAD)

USD 14.1

(-3.49%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 748.95 Million 587.81 Million 700.12 Million 782.61 Million 783.18 Million 540.2 Million
Total Current Assets 616.12 Million 507.93 Million 617.82 Million 717.61 Million 760.25 Million 526.1 Million
Cash And Short Term Investments 438.86 Million 416.82 Million 520.7 Million 631.95 Million 697.42 Million 473.52 Million
Cash and Cash Equivalents 188.65 Million 114.84 Million 147.43 Million 326.02 Million 189.68 Million 134.75 Million
Short Term Investments 250.2 Million 301.97 Million 373.27 Million 305.93 Million 507.74 Million 338.76 Million
Net Receivables 102.35 Million 63.08 Million 65.34 Million 50.28 Million 37.87 Million 27.78 Million
Inventory 35.81 Million 6.63 Million 7.88 Million 9.68 Million 6.34 Million 4.07 Million
Other Current Assets 39.09 Million 21.39 Million 23.89 Million 25.69 Million 18.6 Million 20.72 Million
Total Non-Current Assets 132.83 Million 79.87 Million 82.29 Million 65 Million 22.93 Million 14.09 Million
Net PPE 56.46 Million 61.59 Million 66.31 Million 56.44 Million 12.7 Million 3.3 Million
Good Will And Intangible Assets 65.49 Million - - 1.1 Million 2.58 Million 4.06 Million
Good Will 1.00 - - - - -
Intangible Assets 65.48 Million - - 1.1 Million 2.58 Million 4.06 Million
Long-Term Investments 5.77 Million 12.97 Million 9.37 Million 7.07 Million 7.08 Million 4.82 Million
Tax Assets - - - -7.07 Million -7.08 Million -4.82 Million
Other Non Current Assets 5.1 Million 5.31 Million 6.61 Million 7.44 Million 7.64 Million 6.72 Million
Other Assets - - - - - -
Total Liabilities 317.2 Million 187.39 Million 159.22 Million 155.6 Million 84.04 Million 61.12 Million
Total Current Liabilities 254.25 Million 125.63 Million 96.06 Million 105.96 Million 74.82 Million 59.56 Million
Account Payables 17.54 Million 12.74 Million 6.87 Million 8.49 Million 7.22 Million 3.16 Million
Tax Payables 1.56 Million 377 Thousand - - - -
Short Term Debt 9.4 Million 9.3 Million 8.3 Million 5.08 Million 3.43 Million -
Deferred Revenue 1.56 Million - - - - -
Other Current Liabilities 225.74 Million 103.57 Million 80.88 Million 92.38 Million 64.17 Million 56.39 Million
Total Non Current Liabilities 62.94 Million 61.76 Million 63.16 Million 49.64 Million 9.22 Million 1.55 Million
Long-Term Debt 47.8 Million 52.69 Million 56.12 Million 44.46 Million 6.36 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 15.14 Million 9.07 Million 7.03 Million 5.18 Million 2.86 Million 1.55 Million
Other Liabilities - - - - - -
Total Equity 431.75 Million 400.41 Million 540.89 Million 627 Million 699.13 Million 479.07 Million
Stock Holders Equity 431.75 Million 400.41 Million 540.89 Million 627 Million 699.13 Million 479.07 Million
Common Stock 16 Thousand 16 Thousand 16 Thousand 16 Thousand 15 Thousand 14 Thousand
Retained Earnings -2.43 Billion -2.36 Billion -2.15 Billion -1.98 Billion -1.7 Billion -1.46 Billion
Accumulated other comprehensive income 24 Thousand -975 Thousand -192 Thousand 36 Thousand 297 Thousand -372 Thousand
Common Stock Equity 431.75 Million 400.41 Million 540.89 Million 627 Million 699.13 Million 479.07 Million
Capital Lease Obligation 47.8 Million 52.69 Million 56.12 Million 44.46 Million 6.36 Million -
Total Investments 255.97 Million 301.97 Million 373.27 Million 305.93 Million 507.74 Million 338.76 Million
Total Debt 57.2 Million 62 Million 56.12 Million 44.46 Million 6.36 Million -
Net Debt -131.45 Million -52.84 Million -91.3 Million -281.56 Million -183.31 Million -134.75 Million

Balance Sheet Charts